Literature DB >> 29262351

The Xenobiotic Transporter Mdr1 Enforces T Cell Homeostasis in the Presence of Intestinal Bile Acids.

Wei Cao1, Hisako Kayama2, Mei Lan Chen1, Amber Delmas1, Amy Sun3, Sang Yong Kim4, Erumbi S Rangarajan5, Kelly McKevitt1, Amanda P Beck6, Cody B Jackson1, Gogce Crynen7, Angelos Oikonomopoulos8, Precious N Lacey8, Gustavo J Martinez9, Tina Izard5, Robin G Lorenz10, Alex Rodriguez-Palacios11, Fabio Cominelli11, Maria T Abreu12, Daniel W Hommes8, Sergei B Koralov3, Kiyoshi Takeda2, Mark S Sundrud13.   

Abstract

CD4+ T cells are tightly regulated by microbiota in the intestine, but whether intestinal T cells interface with host-derived metabolites is less clear. Here, we show that CD4+ T effector (Teff) cells upregulated the xenobiotic transporter, Mdr1, in the ileum to maintain homeostasis in the presence of bile acids. Whereas wild-type Teff cells upregulated Mdr1 in the ileum, those lacking Mdr1 displayed mucosal dysfunction and induced Crohn's disease-like ileitis following transfer into Rag1-/- hosts. Mdr1 mitigated oxidative stress and enforced homeostasis in Teff cells exposed to conjugated bile acids (CBAs), a class of liver-derived emulsifying agents that actively circulate through the ileal mucosa. Blocking ileal CBA reabsorption in transferred Rag1-/- mice restored Mdr1-deficient Teff cell homeostasis and attenuated ileitis. Further, a subset of ileal Crohn's disease patients displayed MDR1 loss of function. Together, these results suggest that coordinated interaction between mucosal Teff cells and CBAs in the ileum regulate intestinal immune homeostasis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Crohn’s disease; IBD; MDR1; T cells; Th1; Th17; bile acids; cholestyramine; ileitis

Mesh:

Substances:

Year:  2017        PMID: 29262351      PMCID: PMC5741099          DOI: 10.1016/j.immuni.2017.11.012

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  47 in total

1.  Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease.

Authors:  M M Kosiewicz; C C Nast; A Krishnan; J Rivera-Nieves; C A Moskaluk; S Matsumoto; K Kozaiwa; F Cominelli
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Cells have distinct mechanisms to maintain protection against different reactive oxygen species: oxidative-stress-response genes.

Authors:  Geoffrey W Thorpe; Chii S Fong; Nazif Alic; Vincent J Higgins; Ian W Dawes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-15       Impact factor: 11.205

3.  Endoscopic photoconversion reveals unexpectedly broad leukocyte trafficking to and from the gut.

Authors:  Angela M Morton; Esen Sefik; Rabi Upadhyay; Ralph Weissleder; Christophe Benoist; Diane Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-21       Impact factor: 11.205

4.  MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine.

Authors:  A van Helvoort; A J Smith; H Sprong; I Fritzsche; A H Schinkel; P Borst; G van Meer
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

5.  In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.

Authors:  F Hyafil; C Vergely; P Du Vignaud; T Grand-Perret
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

6.  Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123.

Authors:  C Ludescher; J Thaler; D Drach; J Drach; M Spitaler; C Gattringer; H Huber; J Hofmann
Journal:  Br J Haematol       Date:  1992-09       Impact factor: 6.998

7.  Tissue adaptation of regulatory and intraepithelial CD4⁺ T cells controls gut inflammation.

Authors:  Tomohisa Sujino; Mariya London; David P Hoytema van Konijnenburg; Tomiko Rendon; Thorsten Buch; Hernandez M Silva; Juan J Lafaille; Bernardo S Reis; Daniel Mucida
Journal:  Science       Date:  2016-06-02       Impact factor: 47.728

8.  P-glycoprotein ABCB1: a major player in drug handling by mammals.

Authors:  Piet Borst; Alfred H Schinkel
Journal:  J Clin Invest       Date:  2013-10-01       Impact factor: 14.808

9.  Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.

Authors:  F Powrie; R Correa-Oliveira; S Mauze; R L Coffman
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

10.  Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.

Authors:  Nicholas Arpaia; Clarissa Campbell; Xiying Fan; Stanislav Dikiy; Joris van der Veeken; Paul deRoos; Hui Liu; Justin R Cross; Klaus Pfeffer; Paul J Coffer; Alexander Y Rudensky
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

View more
  28 in total

1.  Lipid Metabolism in Tumor-Infiltrating T Cells.

Authors:  Shangwen He; Ting Cai; Juanjuan Yuan; Xiaojun Zheng; Wei Yang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Determinants of Tissue-Specific Metabolic Adaptation of T Cells.

Authors:  Siva Karthik Varanasi; Sushmitha Vijaya Kumar; Barry T Rouse
Journal:  Cell Metab       Date:  2020-11-11       Impact factor: 27.287

3.  Ten Reasons to Think about Bile Acids in Managing Inflammatory Bowel Disease.

Authors:  Michael Camilleri
Journal:  J Crohns Colitis       Date:  2020-08-31       Impact factor: 9.071

Review 4.  Emerging roles of bile acids in mucosal immunity and inflammation.

Authors:  Mei Lan Chen; Kiyoshi Takeda; Mark S Sundrud
Journal:  Mucosal Immunol       Date:  2019-04-05       Impact factor: 7.313

5.  Lysophosphatidylserines derived from microbiota in Crohn's disease elicit pathological Th1 response.

Authors:  Yuriko Otake-Kasamoto; Hisako Kayama; Hideki Iijima; Kiyoshi Takeda; Toshihiro Kishikawa; Shinichiro Shinzaki; Taku Tashiro; Takahiro Amano; Mizuki Tani; Takeo Yoshihara; Bo Li; Haruka Tani; Li Liu; Akio Hayashi; Daisuke Okuzaki; Daisuke Motooka; Shota Nakamura; Yukinori Okada; Tetsuo Takehara
Journal:  J Exp Med       Date:  2022-05-24       Impact factor: 17.579

Review 6.  Microbial genes and pathways in inflammatory bowel disease.

Authors:  Melanie Schirmer; Ashley Garner; Hera Vlamakis; Ramnik J Xavier
Journal:  Nat Rev Microbiol       Date:  2019-08       Impact factor: 60.633

Review 7.  Microbial modulation of intestinal T helper cell responses and implications for disease and therapy.

Authors:  Markus B Geuking; Regula Burkhard
Journal:  Mucosal Immunol       Date:  2020-08-13       Impact factor: 7.313

Review 8.  Emerging concepts in intestinal immune control of obesity-related metabolic disease.

Authors:  Saad Khan; Helen Luck; Shawn Winer; Daniel A Winer
Journal:  Nat Commun       Date:  2021-05-10       Impact factor: 14.919

Review 9.  Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis.

Authors:  Jie Cai; Lulu Sun; Frank J Gonzalez
Journal:  Cell Host Microbe       Date:  2022-03-09       Impact factor: 21.023

10.  CAR directs T cell adaptation to bile acids in the small intestine.

Authors:  Mei Lan Chen; Xiangsheng Huang; Hongtao Wang; Courtney Hegner; Yujin Liu; Jinsai Shang; Amber Eliason; Huitian Diao; HaJeung Park; Blake Frey; Guohui Wang; Sarah A Mosure; Laura A Solt; Douglas J Kojetin; Alex Rodriguez-Palacios; Deborah A Schady; Casey T Weaver; Matthew E Pipkin; David D Moore; Mark S Sundrud
Journal:  Nature       Date:  2021-04-07       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.